Page 9 - Jonathanw Ayers News Today

IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) has received an average recommendation of “Buy” from the nine brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price objective among brokers […]

Brokerages expect IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) to post $841.21 million in sales for the current quarter, according to Zacks. Five analysts have provided estimates for IDEXX Laboratories’ earnings. The highest sales estimate is $859.40 million and the lowest is $812.00 million. IDEXX Laboratories posted sales of $777.71 million in the same quarter […]

Raymond James Trust N.A. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 13.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,281 shares of the company’s stock after purchasing an additional 150 […]

Chevy Chase Trust Holdings Inc. decreased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 50,915 shares of the company’s stock after selling 1,383 shares during the period. Chevy Chase Trust Holdings Inc. […]

Equities analysts forecast that IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) will announce earnings of $2.26 per share for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for IDEXX Laboratories’ earnings, with the lowest EPS estimate coming in at $2.15 and the highest estimate coming in at $2.33. IDEXX Laboratories posted […]

Whittier Trust Co. decreased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 8.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,514 shares of the company’s stock after selling 218 shares during the quarter. Whittier Trust Co.’s holdings in IDEXX Laboratories […]

44 Wealth Management LLC decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 1.5% during the 4th quarter, HoldingsChannel reports. The fund owned 2,943 shares of the company’s stock after selling 45 shares during the quarter. 44 Wealth Management LLC’s holdings in IDEXX Laboratories were worth $1,938,000 as of its most recent […]

/PRNewswire/ -- Achieves 11% fourth quarter revenue growth as reported and 10.5% organic, driven by 13% CAG Diagnostics recurring revenue growth (reported and...

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results News provided by Share this article WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ --  Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in pet healthcare Delivers full year EPS of $6.71, an increase of 37% on a reported basis and 31% on a ...